Nanjing Medlander Medical Technology Co.,Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 290.46 million compared to CNY 298.32 million a year ago. Revenue was CNY 290.46 million compared to CNY 298.32 million a year ago.

Net income was CNY 84.74 million compared to CNY 98.1 million a year ago. Basic earnings per share from continuing operations was CNY 0.8445 compared to CNY 1.2612 a year ago. Diluted earnings per share from continuing operations was CNY 0.8445 compared to CNY 1.2612 a year ago.